Implementing Precision Medicine in Community-Based Oncology Programs: Three Models
- 1 June 2019
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Oncology Practice
- Vol. 15 (6), 325-329
- https://doi.org/10.1200/jop.18.00661
Abstract
The use of precision medicine and the number of genomic-based treatments and immunotherapies is increasing. Nevertheless, oncology providers face challenges to implementing precision medicine, including in community practices, where most patients receive treatment. On January 31, 2018, ASCO hosted Precision Medicine: Expanding Opportunities, the inaugural event in ASCO’s new State of Cancer Care in America (SOCCA) event series. This article draws from the inaugural SOCCA event and the experiences of the SOCCA event participants to summarize the opportunities and challenges of precision medicine, and to highlight three successful models of implementing precision oncology in large, multisite community practices or networks: (1) Intermountain Healthcare, (2) Levine Cancer Institute, Atrium Health, and (3) National Cancer Care Alliance. The experience of these practices suggests that practice innovations that offer clinical decision support through molecular tumor boards and clinical pathways, and administrative support for prior authorization and clinical trial matching are key to successful implementation of large-scale, community-based precision medicine programs.Keywords
This publication has 27 references indexed in Scilit:
- Guiding Oncology Patients Through the Maze of Precision MedicineJournal of Health Communication, 2016
- Awareness, Understanding, and Adoption of Precision Medicine to Deliver Personalized Treatment for Patients With Cancer: A Multinational Survey Comparison of Physicians and PatientsThe Oncologist, 2016
- Community Oncology Medical Homes: Physician-Driven Change to Improve Patient Care and Reduce CostsJournal of Oncology Practice, 2015
- Precision Medicine — Personalized, Problematic, and PromisingThe New England Journal of Medicine, 2015
- Delivering precision medicine in oncology today and in future—the promise and challenges of personalised cancer medicine: a position paper by the European Society for Medical Oncology (ESMO)Annals of Oncology, 2014
- Molecular Tumor Board: The University of California San Diego Moores Cancer Center ExperienceThe Oncologist, 2014
- Implementing personalized cancer careNature Reviews Clinical Oncology, 2014
- Clinical Analysis and Interpretation of Cancer Genome DataJournal of Clinical Oncology, 2013
- Genomics-Driven Oncology: Framework for an Emerging ParadigmJournal of Clinical Oncology, 2013
- Attitudes of Patients With Cancer About Personalized Medicine and Somatic Genetic TestingJournal of Oncology Practice, 2012